Drugs affecting the autonomic nervous system

Anaesthesia and Intensive Care Medicine

Volumn 12, Issue 2, 2011, Pages 73-77

  Wood, Marcus J ^a   Thompson, Jonathan P ^b  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Autonomic nervous system; catecholamines; parasympathetic; sympathetic

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1 ADRENERGIC RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING); BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CLONIDINE; CORTICOTROPIN; DOBUTAMINE; DOPAMINE; DOPEXAMINE; DOXAZOSIN; EPHEDRINE; FENOLDOPAM; GANGLION BLOCKING AGENT; HEXAMETHONIUM; INDORAMIN; ISOPRENALINE; METARAMINOL; NORADRENALIN; PHENOXYBENZAMINE; PHENTOLAMINE; PHENYLEPHRINE; PRAZOSIN; TAMSULOSIN; TOLAZOLINE; TRIMETAPHAN; UNINDEXED DRUG;

ABDOMINAL CRAMP; ADRENAL MEDULLA; ANAPHYLAXIS; ARTERIAL PRESSURE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BRADYCARDIA; BRAIN BLOOD FLOW; BRONCHODILATATION; CATECHOLAMINE SYNTHESIS; CENTRAL VENOUS PRESSURE; CHEMICAL STRUCTURE; CHRONOTROPISM; CORONARY ARTERY BLOOD FLOW; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DIURESIS; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENDOTRACHEAL TUBE; ENZYME DEGRADATION; FLOPPY IRIS SYNDROME; FLUID THERAPY; GANGLION BLOCK; HEART ARREST; HEART ARRHYTHMIA; HEART MUSCLE CONTRACTILITY; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEART RATE; HUMAN; HYPERTENSION; HYPERTENSIVE CRISIS; HYPOTENSION; INOTROPISM; IRIS DISEASE; KIDNEY BLOOD FLOW; METABOLIC ACIDOSIS; METABOLIC RATE; MIOSIS; MYDRIASIS; NATRIURESIS; NEBULIZER; NOSE CONGESTION; OBSTETRIC ANESTHESIA; ORTHOSTATIC HYPOTENSION; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PULMONARY ARTERY; RAYNAUD PHENOMENON; REFLEX TACHYCARDIA; RISK REDUCTION; SEDATION; SEPSIS; SIDE EFFECT; SKELETAL MUSCLE; SMOOTH MUSCLE RELAXATION; SPLANCHNIC BLOOD FLOW; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TACHYPNEA; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; URINE RETENTION; UTERUS BLOOD FLOW; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION; XEROSTOMIA;

EID: 79851496513     PISSN: 14720299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpaic.2010.10.019     Document Type: Review

References (6)

1. ALS guidelines. http://www.resus.org.uk (accessed 12 May 2010).
2. A. Lisbon Dopexamine, dobutamine, and dopamine increase splanchnic blood flow: what is the evidence? Chest 123 5 Suppl 2003 May 460S 463S (Pubitemid 36549814)
3. D.W. Cooper, M. Carpenter, P. Mowbray, W.R. Desira, D.M. Ryall, and M.S. Kokri Fetal and maternal effects of phenylephrine and ephedrine during spinal anesthesia for cesarean delivery Anesthesiology 97 2002 1582 1590 (Pubitemid 35417460)
4. J.P. Thompson Drugs acting on the cardiovascular system R. Aitkenhead, G. Smith, D. Rowbotham, Textbook of anaesthesia 5th edn. 2007 Churchill Livingstone, Elsevier
5. M. Konishi, G. Haraguchi, and S. Kimura Comparative effects of carvedilol vs bisoprolol for severe congestive heart failure Circ J 74 2010 May 25 1127 1134
6. M.P. Caulfield, and N.J. Birdsall International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors Pharmacol Rev 50 1998 279 290 (Pubitemid 28304029)